Back to search

Article

Dexmedetomidine alleviates LPS-induced neuronal dysfunction via AKT/GSK-3β/CRMP-2 pathway

2020-06-04

Abstract excerpt

<h4>Background: </h4> Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, shows intervention effect on cognitive dysfunction in elderly patients after general anesthesia. However, the underlying pathological mechanism remains to be further elucidated. The aim of the study was to investigate effects of Dex on LPS-induced neuronal damages in cultured hippocampal neurons. Methods We applied LPS to mimic the po...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a03cf7fd-4ec3-5799-9c4a-8d4802de1559
DOI
10.21203/rs.3.rs-27596/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dexmedetomidine alleviates LPS-induced neuronal dysfunction via AKT/GSK-3β/CRMP-2 pathwayDOI 10.21203/rs.3.rs-27596/v1
Select a neighboring publication to make it the new centre.